Abstract
Especially in recent years, there has been increased interest in the clinical use of brain markers such as S100B proteins. To study the activity of the protein S100B in the blood serum of patients with sriatal hyperkinesis (SH), depending on the duration of disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
